ReviewGut2025
Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD.
Giorgos Bamias et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled itcites it
ReviewGut2025
Giorgos Bamias et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.